Home/ Supplements/ Niacin/ OptiMetaboliX Chocolate Mint

OptiMetaboliX Chocolate Mint

product on market Powder XYMOGEN Safety: 97/100
97/100

This product looks safe

  • Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)
  • 48% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product provides macronutrients and niacin to support energy metabolism and cellular function. Research provides strong evidence for the role of protein and niacin in maintaining metabolic health. However, the overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)

Label

Product Label

Label for OptiMetaboliX Chocolate Mint
Open Full PDF View on NIH DSLD →
Details

Label Data

27 Gram(s)
Serving Size
14
Servings
Other Combinations
Product Type
48%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
180 Calorie(s)
Total Fat
5 Gram(s) (8% DV)
Total Carbohydrates
22 Gram(s) (7% DV)
Protein
21 Gram(s) (42% DV)
40 mg (200% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
50 mcg (833% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
5000 mcg (1667% DV)
166.7× RDA — above typical dose 27 studies (A:0, B:11)
35 mg (350% DV)
7.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
40 mg (4% DV)
Iron
6 mg (33% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
500 mcg (417% DV)
14.3× RDA — above typical dose 199 studies (A:1, B:55)
Sodium
390 mg (16% DV)
Potassium
540 mg (15% DV)
Brown Seaweed Blend
500 mg
Cinnamon 10:1 aqueous extract
200 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
50 mg
41.7× RDA — above typical dose 76 studies (A:0, B:33)
2.5 mg
Exceeds UL by 1.4× (UL: 1.8 mg) 1 studies (A:0, B:1)

Other Ingredients

VegaPro Inulin dried Cane syrup Sunflower Oil Cocoa powder Natural flavors Tripotassium Citrate Cellulose Gum Xanthan Gum Medium-Chain Triglyceride Oil Aminogen Guar Gum Stevia leaf extract Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Blend, shake, or briskly stir two level scoops (54 g) into 8-12 oz chilled water and consume one to two times daily; or take one to two scoops approximately 20-30 minutes before each main meal; or use as directed by your healthcare practitioner.

Warnings & Precautions

Consult your healthcare practitioner prior to use.

Not intended for use by pregnant or lactating women or children under 12. Patients taking blood-glucose lowering medication should be monitored for hypoglycemia.

Not intended for use by pregnant or lactating women or children under 12.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

It features InSea2 - an optimized blend of purified polyphenols from wild-crafted brown seaweed.

OptiMetaboliX also delivers other innovative ingredients, including VegaPro - a proprietary sugar-free, sweetener-free, low-allergy-potential source of vegetable protein from pea protein isolate and rice protein - and CinSulin, a patented water extract of cinnamon with a potent 10:1 yield ratio.

These principal ingredients are complemented by the inclusion of benfotiamine to boost transketolase activity; alpha-lipoic acid; green tea leaf extract; vanadium, chromium, and zinc as Albion TRAACS chelates; 5-MTHF (bioactive folate) as Quatrefolic; fiber from inulin; and other key vitamins and minerals.

Does Not Contain: Wheat, gluten, yeast, soy protein, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or artificial preservatives.

21g Protein

V VegaPro 100% Vegan 100% Gluten-free

V VegaPro 100% Vegan 100% Gluten-free

Additional Information

ZLB-GLYCHOCMINT-04 REV. 031516

GMP Compliant Third-Party Verified

Scan to learn more! This package is completely recyclable

Professional use only

The labeling on this product does not comply with California's Proposition 65. Therefore, this product may not be sold in California.

InSea2 uniquely slows carbohydrate digestion and assimilation and can reduce the impact of high-glycemic foods. This newly developed, next generation dual carb controller is 100% natural, has an excellent safety profile, and is friendly to the gastrointestinal tract.

Cinnamon has been studied extensively for its roles in supporting healthy glucose uptake, glycogen synthesis, and insulin action, along with maintaining blood lipids already within the normal range.

Storage: Keep closed in a cool, dry place out of reach of children.

For support of healthy glucose and insulin metabolism

ePV:

V VegaPro 100% Vegan 100% Gluten-free

Metadata

Product Details

UPC / SKU8 71149 00351 7
DSLD Entry Date2017-01-25
Product TypeOther Combinations
FormPowder
BrandXYMOGEN
DSLD ID69843
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.